Skip to content
Home/Companies/Healthcare/Talkiatry
Talkiatry

Talkiatry

Healthcare·US·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Talkiatry?

Talkiatry is currently owned by Blisce through Blisce Fund II (2023 vintage), since 2023.

Hand-verified · updated 2026-04-21

Blisce
Investor
Blisce
Blisce Fund II · 2023 · VC

Key facts

HQFrance
SectorHealthcare
Websitewww.talkiatry.com

More from Blisce Fund II

Other portfolio companies in the same fund.

Almetra (Deltia)
Almetra (Deltia)
Active
SoftwareGermany· 2026
Ami Labs
Active
AI/MLFrance· 2026
evroc
evroc
Active
Cloud InfrastructureSweden· 2024
Reforest'Action
Reforest'Action
Active
IndustrialsFrance· 2024
Local Infusion
Local Infusion
Active
HealthcareUS· 2023
Too Good To Go
Active
FoodTechDenmark· 2023

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Talkiatry

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Talkiatry?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Talkiatry.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue